1. Bartolommei, N., et al., 2012. Catatonia: A critical review and therapeutic recommendations. Journal of Psychopathology, 18(3), pp. 234-46.
2. Bouza, C., Lápez Cuadrado, T. & Amate, J. M., 2010. 'Physical disease in schizophrenia: A population-based analysis in Spain', BMC Public Health. BioMed Central, 10(1), p. 745. [DOI:10.1186/1471-2458-10-745] [
DOI:10.1186/1471-2458-10-745]
3. Daniels, J., 2009. Catatonia: Clinical aspects and correlates'. Journal of Neuropsychiatry, 21(4), pp. 371-80. [DOI:10.1176/jnp.2009.21.4.371] [PMID] [
DOI:10.1176/jnp.2009.21.4.371]
4. England, M. L., et al., 2011. Catatonia in psychotic patients: Clinical features and treatment response. Journal of Neuropsychiatry, 23(2), pp. 223-26. [DOI:10.1176/appi.neuropsych.23.2.223] [
DOI:10.1176/appi.neuropsych.23.2.223]
5. Fink, M., & Taylor, M. A., 2009. The catatonia syndrome. Archives of General Psychiatry, 66(11), pp. 1173-7. [DOI:10.1001/archgenpsychiatry.2009.141] [
DOI:10.1001/archgenpsychiatry.2009.141]
6. Guggenheim, F. G. & Babigian, H. M., 1974. Catatonic schizophrenia: Epidemiology and clinical course: A 7-year register study of 798 cases. Journal of Nervous and Mental Disease, 158(4), pp. 291-305. [DOI:10.1097/00005053-197404000-00007] [
DOI:10.1097/00005053-197404000-00007]
7. Kavak, F., 2018. Determination of adherence to treatment of schizophrenia patients in Turkey. Annals of Clinical and Laboratory Research, 6(2), pp. 7-11. [DOI:10.21767/2386-5180.100234] [
DOI:10.21767/2386-5180.100234]
8. Leslie, D. L. & Rosenheck, R. A., 2004. Adherence of schizophrenia pharmacotherapy to published treatment recommendations: Patient, facility, and provider predictors. Schizophrenia Bulletin, 30(3), pp. 649-58. [DOI:10.1093/oxfordjournals.schbul.a007112] [
DOI:10.1093/oxfordjournals.schbul.a007112]
9. Martényi, F. et al., 2001. An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms. Journal of Clinical Psychiatry, 62(Suppl.2), pp. 25-7. [PMID] [
PMID]
10. Northoff, G., et al., 1999. Catatonia as a psychomotor syndrome: A rating scale and extrapyramidal motor symptoms. Movement Disorders, 14(3), pp. 404-16. [DOI:10.1002/1531-8257(199905)14:33.0.CO;2-5]
https://doi.org/10.1002/1531-8257(199905)14:3<404::AID-MDS1004>3.0.CO;2-5 [
DOI:10.1002/1531-8257(199905)14:33.0.CO;2-5]
11. Quigley, J., Lommel, K. M. & Coffey, B., 2009. Catatonia in an adolescent with asperger's disorder. Journal of Child and Adolescent Psychopharmacology, 19(1), pp. 93-6. [DOI:10.1089/cap.2009.1913] [
DOI:10.1089/cap.2009.1913]
12. Tandon, R., et al., 2013. Catatonia in DSM-5. Schizophrenia Research, 150(1), pp. 26-30. [DOI:10.1016/j.schres.2013.04.034] [
DOI:10.1016/j.schres.2013.04.034]
13. Ungvari, G. S. et al., 2018. Schizophrenia with prominent catatonic features: A selective review. Schizophrenia Research, 200, pp. 77-84. [DOI:10.1016/j.schres.2017.08.008] [
DOI:10.1016/j.schres.2017.08.008]
14. Usman, D. M. et al., 2011. Comparison of catatonia presentation in patients with schizophrenia and mood disorders in Lagos, Nigeria. Iranian Journal of Psychiatry, 6(1), pp. 7-11. [PMCID] [
PMID] [
PMCID]
15. Waris, P. et al., 2014. Catatonic features in adolescents with schizophrenia with and without a comorbid pervasive developmental disorder. Child and Adolescent Psychiatry and Mental Health, 8(1), pp. 1-7. [DOI:10.1186/1753-2000-8-16] [
DOI:10.1186/1753-2000-8-16]